Profile
David I.
Stirling has a career history that includes founding positions at two companies.
He founded Celgene SAS in 1986 and BioTheryX, Inc. in 2007.
At BioTheryX, Inc., he currently holds the title of Director.
David I. Stirling active positions
Companies | Position | Start |
---|---|---|
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Founder | 2006-12-31 |
Former positions of David I. Stirling
Companies | Position | End |
---|---|---|
Celgene SAS
Celgene SAS Pharmaceuticals: MajorHealth Technology Celgene SAS wholesales pharmaceutical products. Its products include Revlimid, vidaza, thalidomide, imnovid, Abraxane and Otezla. The company was founded in 1984 and is headquartered in Paris La Défense, France. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Health Technology |
Celgene SAS
Celgene SAS Pharmaceuticals: MajorHealth Technology Celgene SAS wholesales pharmaceutical products. Its products include Revlimid, vidaza, thalidomide, imnovid, Abraxane and Otezla. The company was founded in 1984 and is headquartered in Paris La Défense, France. | Health Technology |
- Stock Market
- Insiders
- David I. Stirling